Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jack Kaye currently holds 25,996 shares of KERYX BIOPHARMACEUTICALS INC (KERX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jack Kaye has been a net seller of KERX stock. They have purchased $29.8K and sold $683.5K worth of shares.
Jack Kaye's most recent insider trade was on Jun 17, 2026, when they sold 5,295 shares at $0.00 per share.
Jack Kaye serves as Executive at KERYX BIOPHARMACEUTICALS INC (KERX). They have executed 47 insider transactions totaling $713.3K over their tenure at the company.
Jack Kaye holds the position of Executive at KERYX BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Jack Kaye has shown a selling trading pattern, with $29.8K in total purchases and $683.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jack Kaye was on Jun 17, 2026, when they sold $225.4K worth of QURE shares. This transaction involved 5,295 shares at $42.57 per share.
Jack Kaye currently owns 25,996 shares of KERYX BIOPHARMACEUTICALS INC (KERX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jack Kaye's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jack Kaye has 47 Form 4 filings on record as an insider at KERYX BIOPHARMACEUTICALS INC.
Set alerts for Jack Kaye and 40,000+ other insiders.